HBK Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

HBK Investments’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,176,454	Closed	-$525M	–	986
2021 Q2	$525M	Buy	+3,176,454	New	+$530M	1.84%	8
2017 Q4	–	Sell	-26,230	Closed	-$2M	–	1191
2017 Q3	$2M	Buy	26,230 +19,130	+269%	+$1.45M	0.01%	450
2017 Q2	$533K	Buy	7,100 +627	+10%	+$43.5K	﹤0.01%	708
2017 Q1	$422K	Buy	+6,473	New	+$381K	﹤0.01%	540
2016 Q4	–	Sell	-12,587	Closed	-$711K	–	932
2016 Q3	$711K	Sell	12,587 -17,313	-58%	-$849K	0.01%	581
2016 Q2	$1.25M	Buy	29,900 +23,000	+333%	+$1.06M	0.01%	517
2016 Q1	$295K	Buy	+6,900	New	+$292K	﹤0.01%	833

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

HBK Investments's PRAH Position: Q3 2021 in Review

HBK Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 3,176,454 shares — an estimated $525M sold.

HBK Investments first reported a position in PRAH in Q1 2016 and held it in 7 quarters. The position peaked at $525M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

HBK Investments reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
HBK Investments sold 3,176,454 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $525M.
HBK Investments first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 7 quarters.
HBK Investments's PRA Health Sciences, Inc. position peaked at $525M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on HBK Investments's 13F filing for Q3 2021, filed 15 Nov 2021.